Alecia A. DeCoudreaux - 21 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Alecia A. DeCoudreaux
Issuer symbol
CVS
Transactions as of
21 Nov 2024
Net transactions value
+$125,625
Form type
4
Filing time
25 Nov 2024, 17:39:05 UTC
Previous filing
17 May 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 2,970 21 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Deferred Stock Units Award $125,625 +2,200 +6.7% $57.10 34,934 21 Nov 2024 Common Stock 2,200 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2 Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.